Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Cash from Investing Activities (2017 - 2025)

Dianthus Therapeutics has reported Cash from Investing Activities over the past 8 years, most recently at -$201.3 million for Q3 2025.

  • Quarterly results put Cash from Investing Activities at -$201.3 million for Q3 2025, up 22.4% from a year ago — trailing twelve months through Sep 2025 was -$183.1 million (up 32.65% YoY), and the annual figure for FY2024 was -$286.8 million, down 1516.15%.
  • Cash from Investing Activities for Q3 2025 was -$201.3 million at Dianthus Therapeutics, down from $26.4 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for DNTH hit a ceiling of $26.4 million in Q2 2025 and a floor of -$259.4 million in Q3 2024.
  • Median Cash from Investing Activities over the past 4 years was -$6.9 million (2022), compared with a mean of -$32.4 million.
  • Biggest five-year swings in Cash from Investing Activities: surged 17048.84% in 2023 and later tumbled 2154.36% in 2024.
  • Dianthus Therapeutics' Cash from Investing Activities stood at -$12.7 million in 2022, then skyrocketed by 34.96% to -$8.2 million in 2023, then tumbled by 180.56% to -$23.1 million in 2024, then tumbled by 770.94% to -$201.3 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$201.3 million (Q3 2025), $26.4 million (Q2 2025), and $14.8 million (Q1 2025) per Business Quant data.